Chronic Myelogenous Leukaemia (CML) is a slow-growing type of blood cancer that begins in the bone marrow and primarily affects a type of white blood cell called granulocytes. Unlike acute leukaemias, CML may not cause immediate symptoms, but over time, it can significantly impact overall health if left untreated.
Thanks to medical breakthroughs—especially targeted therapy using Tyrosine Kinase Inhibitors (TKIs)—CML is now considered one of the most manageable forms of leukaemia. Many patients live long, normal lives with proper treatment.
For international patients, CML treatment in India offers advanced care at a fraction of Western costs. The total cost of diagnosis and treatment typically ranges from $3,000 to $30,000, depending on the treatment plan and the hospital. In contrast, annual treatment costs in the United States may exceed $100,000–$150,000.
India combines affordability with access to internationally accredited hospitals, advanced molecular laboratories, and experienced haematologists.
What Is Chronic Myelogenous Leukaemia (CML)?
Chronic Myelogenous Leukaemia is a cancer that starts in the blood-forming cells of the bone marrow. It is characterised by a genetic mutation known as the Philadelphia chromosome, which produces an abnormal protein called BCR-ABL.
This abnormal protein causes white blood cells to grow uncontrollably.
Unlike acute leukaemias, CML usually develops slowly and progresses in stages. However, without treatment, it can transform into a more aggressive leukaemia.
Phases of CML
CML has three clinical phases:
1️⃣ Chronic Phase
- Earliest and most common stage
- Symptoms may be mild or absent
- Best response to targeted therapy
- The majority of patients are diagnosed here
2️⃣ Accelerated Phase
- Increasing abnormal blood cells
- Symptoms become more noticeable
- Disease becomes harder to control
3️⃣ Blast Crisis
- Advanced and aggressive stage
- Behaves like acute leukaemia
- Requires urgent intensive treatment
- Prognosis is poorer than in earlier phases
Early detection in the chronic phase offers the best long-term outcomes.
Who Is at Risk for CML?
CML commonly affects:
- Adults over 40 years
- Slightly more common in men
- Individuals exposed to high radiation levels
Unlike many cancers, lifestyle factors such as smoking or diet are not strongly linked to CML.
There is currently no proven method to prevent CML.
Early Symptoms of Chronic Myelogenous Leukaemia
CML is often called a “silent” cancer because early symptoms are subtle.
Common Early Signs:
- Persistent fatigue
- Unexplained weight loss
- Night sweats
- Low-grade fever
- Fullness in the upper left abdomen (enlarged spleen)
- Mild bruising or bleeding
Advanced Symptoms:
- Bone pain
- Severe anaemia
- Frequent infections
- Swollen lymph nodes
- Abdominal swelling
If symptoms persist or worsen, immediate medical evaluation is recommended.
How Is CML Diagnosed?
Accurate diagnosis is essential for selecting the right treatment.
1️⃣ Complete Blood Count (CBC)
Shows very high white blood cell counts.
2️⃣ Peripheral Blood Smear
Reveals immature or abnormal cells.
3️⃣ Bone Marrow Biopsy
Confirms diagnosis and determines phase.
4️⃣ Cytogenetic Testing
Detects the Philadelphia chromosome.
5️⃣ FISH Test
Identifies BCR-ABL gene fusion quickly.
6️⃣ PCR Test (Most Sensitive)
Measures BCR-ABL levels.
Used for both diagnosis and treatment monitoring.
Cost of CML Diagnosis in India:
Approximately $300–$900, compared to $2,000–$4,000 in Western countries.
Best Treatment Options for CML in India
Targeted Therapy (First-Line Treatment)
The standard treatment for CML is Tyrosine Kinase Inhibitors (TKIs).
Common TKIs Used:
- Imatinib
- Dasatinib
- Nilotinib
- Bosutinib
- Ponatinib
These oral medications block the abnormal BCR-ABL protein and stop cancer cell growth.
Most patients take TKIs daily for long-term disease control.
India offers both branded and affordable generic versions, significantly reducing costs.
Stem Cell (Bone Marrow) Transplant
Recommended in:
- TKI-resistant CML
- Accelerated or blast phase
- Younger high-risk patients
A transplant may offer a potential cure in selected cases.
India has advanced transplant centres with internationally trained specialists.
Chemotherapy
Used mainly in:
- Blast crisis phase
- Before or after transplant
- Rare TKI-resistant cases
Clinical Trials & Advanced Therapies
India participates in international clinical trials offering:
- Next-generation TKIs
- Combination therapies
- Immunotherapy approaches
Eligible patients may access innovative treatments at reduced cost.
Cost of Chronic Myelogenous Leukaemia Treatment in India
| Treatment Type | Approximate Cost (USD) |
| Diagnosis | $300 – $900 |
| TKI Therapy (annual) | $3,000 – $12,000 |
| Advanced TKIs | $10,000 – $20,000 |
| Bone Marrow Transplant | $20,000 – $30,000 |
Western countries may charge $ 100,000 or more annually for branded therapy.
India offers savings of up to 70–80% without compromising quality.
Recovery and Success Rate of CML Treatment
Thanks to TKIs:
- 5-year survival rate exceeds 90%
- 10-year survival rate is 80–85%
- Many patients achieve Major Molecular Response (MMR)
- Some achieve Complete Molecular Remission (CMR)
CML is now treated as a chronic condition rather than a fatal disease.
Some patients may eventually discontinue therapy under strict medical supervision.
Why Choose India for CML Treatment?
- Internationally accredited hospitals
- Advanced molecular diagnostic labs
- Experienced haematologists
- Affordable generic medications
- No waiting lists
- Dedicated international patient services
India combines clinical excellence with cost efficiency.
Conclusion
Chronic Myelogenous Leukaemia (CML) is no longer the life-threatening diagnosis it once was. With early diagnosis and targeted therapy, most patients can lead long, productive lives.
India has emerged as a leading global destination for affordable and advanced CML treatment, offering access to modern targeted drugs, molecular monitoring, and bone marrow transplantation at significantly lower costs than Western countries.
If you are newly diagnosed or seeking a second opinion, early consultation with an experienced haematologist is essential.
Frequently Asked Questions
What are the early symptoms of Chronic Myelogenous Leukaemia?
Fatigue, night sweats, weight loss, and abdominal fullness due to spleen enlargement.
What causes Chronic Myelogenous Leukemia?
CML is caused by a genetic mutation known as the Philadelphia chromosome (BCR-ABL gene fusion).
How is CML diagnosed?
Through CBC, bone marrow biopsy, cytogenetic testing, FISH, and PCR testing.
What is the best treatment for CML?
Tyrosine Kinase Inhibitors (TKIs) are the first-line treatment and are highly effective.
What is the life expectancy for CML patients?
With proper treatment, many patients live normal life spans, especially when diagnosed in the chronic phase.
